General Atlantic Invests in Javara
April 12, 2022
Javara, an integrated research organization that embeds clinical trials at the point of care, has secured a Series B growth investment from global growth equity firm General Atlantic. The capital will be used to drive geographic expansion and technology advancement as General Atlantic joins Javara's board to support scaling of its clinical research-as-care model.
- Buyers
- General Atlantic
- Targets
- Javara
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
General Atlantic and Kedaara Capital Acquire Stake in ASG Eye Hospital from Investcorp
September 19, 2022
Healthcare Services
General Atlantic and Kedaara Capital acquired a stake in ASG Eye Hospital as part of a INR 15 billion growth-capital funding round, with Investcorp selling its shareholding. The investment will support ASG’s continued expansion across India — including its recent acquisition of Vasan Eye — and further scale the company’s specialty eye-hospital network.
-
Evestia Clinical Merges with Atlantic Research Group
July 15, 2025
Healthcare Services
Kester Capital-backed Evestia Clinical has merged with US-based Atlantic Research Group (ARG) to create a larger independent specialist CRO with dual headquarters in Letchworth, UK and Charlottesville, VA. The combination expands Evestia's US footprint and adds neurology and late-stage clinical trial capabilities while broadening therapeutic expertise across oncology, rare diseases, immunology and inflammation.
-
Altaris Capital Acquires Veranova (Johnson Matthey Health business)
June 1, 2022
Pharmaceuticals
Altaris Capital Partners completed the acquisition of Veranova (formerly Johnson Matthey's Health business) from Johnson Matthey PLC for total consideration of up to £325 million, with Johnson Matthey retaining approximately a 30% equity stake. Veranova is a global CDMO focused on specialty and complex active pharmaceutical ingredients (APIs), headquartered in Wayne, Pennsylvania, with roughly 900 employees across seven development and manufacturing sites in North America, Europe and Asia.
-
Arlington Capital Partners Makes Majority Investment in Everest Clinical Research Corporation
December 7, 2020
Healthcare Services
Washington, D.C.-based private equity firm Arlington Capital Partners has made a majority investment in Toronto-headquartered Everest Clinical Research Corporation, with Everest's founding shareholders and senior management rolling equity and continuing to lead the company. Everest is a full-service contract research organization (CRO) with ~300 employees across Toronto, Little Falls (NJ) and Shanghai; Arlington will support expansion of service lines, capabilities and headcount to drive growth.
-
General Atlantic Makes Strategic Growth Investment in GoodVets
September 13, 2023
Healthcare Services
General Atlantic has made a strategic growth investment in GoodVets, joining existing investor SkyKnight Capital to support the veterinary care platform's de novo expansion. The capital and strategic resources will help GoodVets accelerate new clinic openings and build a scaled national provider of general and urgent veterinary care.
-
Genstar Capital Acquires Advarra from Linden Capital Partners
June 6, 2019
Healthcare Services
Genstar Capital has signed and completed a definitive agreement to acquire Advarra, a leading provider of IRB, IBC and research compliance services, from Linden Capital Partners; Linden intends to reinvest as a minority investor upon closing. Advarra, headquartered in Columbia, Maryland, serves pharma, biotech, medical device companies, CROs and academic medical centers (relationships with over 3,200 institutional sites); Genstar plans to expand Advarra’s capabilities and pursue organic growth and strategic acquisitions.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.